Effect of the probiotic capsule on gut microbiome in colorectal cancer

Effect of the probiotic capsule on gut microbiome in patients with previous colorectal cancer condition

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20240929001

Enrollment

Registered

2024-09-29

Start date

2024-10-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with colon cancer had imbalance 0f gut microbiome Probiotics, Gut, Microbiome

Interventions

Tested group 10 volunteers receive probiotic tested capsule containing live probiotic strains 2 billion cells 1capsule per day for 30 days after breakfast meal Collect the feces samples before and

Active Comparator Dietary Supplement,Placebo Comparator No treatment

probiotic group,Control group

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Volunteers age 30-70 years old 2. had been diagnosed as colon cancer grade 2 -3, already received standard treatment at least 12 months, having serum CEA less than 5 ng/ml

Exclusion criteria

Exclusion criteria: 1. having systemic diseases e.g. DM, IBD, Peritonitis 2. having immune deficiency 3. taking antibiotics within 12 weeks 4. regular taking fermented foods

Design outcomes

Primary

Measure	Time frame
bactrial pathogens 4 weeks software analysis	—

Secondary

Measure	Time frame
gut microbome 4 weeks software analysis	—

Countries

Thailand

Contacts

Public ContactRawee Teanpaisan

Prince of Songkla University

rawee.t@psu.ac.th66896555836

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026